{
  "meta": {
    "id": "test10",
    "title": "Pharmacology E&D 1 (Mission NEET PG 1.0) - 27-09-2023 - 2023-09-27",
    "category": "NEET PG PYQ"
  },
  "questions": [
    {
      "text": "A 67-year-old man with a history of chronic obstructive pulmonary disease (COPD) is admitted to the intensive care unit for acute exacerbation of his respiratory symptoms. Cultures are taken, and Pseudomonas aeruginosa is isolated from his sputum sample. The healthcare team is considering various antibiotic options to target this specific bacterial strain. Which of the following antibiotics is not effective against infections caused by Pseudomonas aeruginosa?",
      "options": [
        {
          "label": "A",
          "text": "Ceftazidime",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ciprofloxacin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rifampicin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Vancomycin",
          "correct": true
        }
      ],
      "correct_answer": "D. Vancomycin",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/2.jpg"
      ],
      "explanation": "<p><strong>Ans. D. Vancomycin</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "88bdf95f",
      "audio": ""
    },
    {
      "text": "Adrenaline acting via beta 2 receptors causes bronchodilation whereas histamine acting through H1 receptors cause bronchoconstriction. Which type of antagonism it is?",
      "options": [
        {
          "label": "A",
          "text": "Pharmacological antagonism",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chemical antagonism",
          "correct": false
        },
        {
          "label": "C",
          "text": "Physical antagonism",
          "correct": false
        },
        {
          "label": "D",
          "text": "Physiological antagonism",
          "correct": true
        }
      ],
      "correct_answer": "D. Physiological antagonism",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Physiological Antagonism</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of Options:</li><li>\u2022 A) Pharmacological Antagonism: This term generally refers to one drug reducing the effectiveness of another drug, typically through receptor competition or a similar mechanism at the molecular level. Since adrenaline and histamine act on different receptors to produce opposite physiological effects, this option is not correct.</li><li>\u2022 B) Chemical Antagonism: This occurs when one drug directly reacts with another to neutralize its effects e.g. antacids neutralize gastric acid and protamine neutralize heparin. There is no direct chemical reaction between adrenaline and histamine, making this option incorrect.</li><li>\u2022 C) Physical Antagonism: This would imply that the drugs physically interfere with each other e.g. charcoal adbsorbs many drugs and is used in drug poisoning.</li><li>\u2022 D) Physiological Antagonism: This is the correct answer. Physiological antagonism occurs when two drugs produce opposite effects in the same physiological system. Adrenaline causes bronchodilation via beta-2 receptors, while histamine causes bronchoconstriction via H1 receptors. These drugs act on different receptor types but have opposite effects on the same physiological system, namely the bronchial smooth muscle.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "daee7f65",
      "audio": ""
    },
    {
      "text": "A farmer presents to the emergency department with pinpoint pupil, diarrhea, sweating, excessive lacrimation, salivation and garlic dour. on examination there is bradycardia and BP is 80/60 mm Hg pulse rate is 56/min and his plasma cholinesterase level was 52 U/mL. Which of the following is antidote for treatment of this patient?",
      "options": [
        {
          "label": "A",
          "text": "Pralidoxine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Atropine",
          "correct": true
        },
        {
          "label": "C",
          "text": "Physostigmine",
          "correct": false
        },
        {
          "label": "D",
          "text": "N-acetylcysteine",
          "correct": false
        }
      ],
      "correct_answer": "B. Atropine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Atropine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of Options:</li><li>\u2022 A) Pralidoxine: This drug is typically used alongside atropine for treating organophosphate poisoning to reactivate acetylcholinesterase, but it does not counteract the cholinergic symptoms the patient is experiencing.</li><li>\u2022 B) Atropine: This is the correct answer. The farmer's symptoms such as pinpoint pupils, excessive salivation, and bradycardia suggest cholinergic toxicity, likely from organophosphate exposure. Atropine acts as an antagonist at muscarinic cholinergic receptors and would counteract many of the symptoms observed.</li><li>\u2022 C) Physostigmine: This drug is a cholinesterase inhibitor and would worsen the symptoms of cholinergic toxicity, making it an inappropriate treatment in this case.</li><li>\u2022 D) N-acetylcysteine: This is commonly used for acetaminophen overdose and would not be effective for treating symptoms of cholinergic toxicity.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "32e8de2d",
      "audio": ""
    },
    {
      "text": "A 65-year-old man with a history of benign prostatic hyperplasia (BPH) is scheduled to receive a new medication. The physician explains the mechanism of action and potential side effects of finasteride to the patient and his family. Which of the following is true about finasteride?",
      "options": [
        {
          "label": "A",
          "text": "It increases the production of testosterone.",
          "correct": false
        },
        {
          "label": "B",
          "text": "It act as an antagonist of androgen receptors.",
          "correct": false
        },
        {
          "label": "C",
          "text": "It can cause sexual side effects such as decreased libido and erectile dysfunction.",
          "correct": true
        },
        {
          "label": "D",
          "text": "It is only effective in reducing symptoms of BPH in the short-term.",
          "correct": false
        }
      ],
      "correct_answer": "C. It can cause sexual side effects such as decreased libido and erectile dysfunction.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. It can cause sexual side effects such as decreased libido and erectile dysfunction.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Finasteride like drugs are a class of medications used to treat BPH by reducing the size of the prostate gland. They work by inhibiting the enzyme 5 alpha reductase, which converts testosterone to dihydrotestosterone (DHT). By reducing the levels of DHT, 5 alpha reductase inhibitors can shrink the prostate gland and improve urinary symptoms associated with BPH. A potential side effect of these medications is sexual dysfunction, including decreased libido and erectile dysfunction. These medications can take several months to achieve their maximum effect and can provide long-term relief of BPH symptoms.</li><li>\u2022 Finasteride like drugs are a class of medications used to treat BPH by reducing the size of the prostate gland.</li><li>\u2022 They work by inhibiting the enzyme 5 alpha reductase, which converts testosterone to dihydrotestosterone (DHT).</li><li>\u2022 By reducing the levels of DHT, 5 alpha reductase inhibitors can shrink the prostate gland and improve urinary symptoms associated with BPH.</li><li>\u2022 A potential side effect of these medications is sexual dysfunction, including decreased libido and erectile dysfunction.</li><li>\u2022 These medications can take several months to achieve their maximum effect and can provide long-term relief of BPH symptoms.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1833a798",
      "audio": ""
    },
    {
      "text": "Which of the following is not a correct match of symptoms and action of antidepressants and the receptors involved?",
      "options": [
        {
          "label": "A",
          "text": "Sedation and weight gain - H1 receptor blockade",
          "correct": false
        },
        {
          "label": "B",
          "text": "Dry mouth and constipation - Muscarinic receptor blockade",
          "correct": false
        },
        {
          "label": "C",
          "text": "Sexual dysfunction and anorgasmia \u2013 5HT reuptake inhibition",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hypertension - Alpha-1 receptor blockade",
          "correct": true
        }
      ],
      "correct_answer": "D. Hypertension - Alpha-1 receptor blockade",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/5_hniNzH3.jpg"
      ],
      "explanation": "<p><strong>Ans. D. Hypertension - Alpha-1 receptor blockade</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "36f95b89",
      "audio": ""
    },
    {
      "text": "In a dog blood pressure experiment, a researcher injected phentolamine first followed by epinephrine and the recordings of the effect are shown in the diagram given below. This phenomenon is known as?",
      "options": [
        {
          "label": "A",
          "text": "Tachyphylaxis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Biphasic response of epinephrine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Vasomotor reversal of Dale",
          "correct": true
        },
        {
          "label": "D",
          "text": "Phentolamine epinephrine coupling",
          "correct": false
        }
      ],
      "correct_answer": "C. Vasomotor reversal of Dale",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/6.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Vasomotor reversal of Dale</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "10fd511f",
      "audio": ""
    },
    {
      "text": "A 34-year-old male with a history of tuberculosis presents to the clinic with complaints of cough, fever, and night sweats. The patient reports completing a course of anti-tuberculosis medications but reports recurrent symptoms. Sputum culture reveals that the mycobacterium is resistant to isoniazid, rifampicin and levofloxacin and sensitive to other first line drugs and linezolide as well as bedaquiline. Which type of tuberculosis it can be referred to as?",
      "options": [
        {
          "label": "A",
          "text": "MDR Tuberculosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pre-XDR Tuberculosis",
          "correct": true
        },
        {
          "label": "C",
          "text": "XDR Tuberculosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Rifampicin resistant Tuberculosis",
          "correct": false
        }
      ],
      "correct_answer": "B. Pre-XDR Tuberculosis",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/7.jpg"
      ],
      "explanation": "<p><strong>Ans. B. Pre-XDR Tuberculosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The patient's history and sputum culture indicate that the mycobacterium is resistant to isoniazid, rifampicin and levofloxacin, but is sensitive to other first-line drugs and linezolide, as well as bedaquiline. Based on this information, the patient's condition can be referred to as Pre-XDR Tuberculosis</li><li>\u2022 The patient's history and sputum culture indicate that the mycobacterium is resistant to isoniazid, rifampicin and levofloxacin, but is sensitive to other first-line drugs and linezolide, as well as bedaquiline. Based on this information, the patient's condition can be referred to as Pre-XDR Tuberculosis</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e24f7490",
      "audio": ""
    },
    {
      "text": "A 29-year-old researcher is studying a novel antiviral drug that has shown promise in in-vitro studies. The researcher is in the process of planning the clinical development of the drug. She explains to her team that the next step involves a phase zero clinical trial, which will be crucial in determining whether to move on to phase I trials. The team is confused, as they are not familiar with phase zero clinical trials. Which of the following statements is true regarding phase zero clinical trials, that would help the team understand its significance?",
      "options": [
        {
          "label": "A",
          "text": "Phase zero clinical trials are typically conducted in animal models to assess the safety and efficacy of a new drug.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Phase zero clinical trials are comprehensive studies designed to provide conclusive data on the safety and efficacy of a new drug.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Phase zero clinical trials primarily focus on pharmacokinetics, particularly on the movement of the drug in the human body.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Phase zero clinical trials are also known as therapeutic trials and aim to cure or mitigate symptoms of the disease in question.",
          "correct": false
        }
      ],
      "correct_answer": "C. Phase zero clinical trials primarily focus on pharmacokinetics, particularly on the movement of the drug in the human body.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Phase zero clinical trials primarily focus on pharmacokinetics, particularly on the movement and metabolism of the drug in the human body.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of all the options:</li><li>\u2022 A) Phase zero clinical trials are typically conducted in animal models to assess the safety and efficacy of a new drug: This statement is incorrect. Phase zero clinical trials are human trials that precede phase I trials. They are not animal studies.</li><li>\u2022 B) Phase zero clinical trials are comprehensive studies designed to provide conclusive data on the safety and efficacy of a new drug: This is incorrect. Phase zero trials are not designed to provide comprehensive data on safety and efficacy but are focused on pharmacokinetics and perhaps some initial pharmacodynamic data.</li><li>\u2022 C) Phase zero clinical trials primarily focus on pharmacokinetics, particularly on the movement of the drug in the human body: This is correct. The main aim of phase zero trials is to gather preliminary data on pharmacokinetics and assess whether the drug behaves in humans as it does in preclinical models.</li><li>\u2022 D) Phase zero clinical trials are also known as therapeutic trials and aim to cure or mitigate symptoms of the disease in question: This is incorrect. Phase zero trials are exploratory trials that precede phase I trials; they are not focused on therapeutic outcomes.</li><li>\u2022 Therefore, the statement that would best help the team understand the significance of phase zero trials is that they primarily focus on pharmacokinetics and provide initial human data on the movement and metabolism of the drug.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f2a069e2",
      "audio": ""
    },
    {
      "text": "A 65-year-old male with a history of chronic kidney disease presents to the emergency department with complaints of muscle weakness, nausea, and abdominal cramping. Laboratory testing shows that the patient has hyperkalemia, with a serum potassium level of 6.5 mEq/L. The patient's medications are reviewed, and it is discovered that he has been taking several drugs for his cardiac conditions and hypertension. Upon further evaluation, it is determined that one of these drugs may be contributing to the patient's hyperkalemia. Which of the following drugs should be stopped in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Hydrochlorothiazide",
          "correct": false
        },
        {
          "label": "B",
          "text": "Enalapril",
          "correct": true
        },
        {
          "label": "C",
          "text": "Amlodipine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Furosemide",
          "correct": false
        }
      ],
      "correct_answer": "B. Enalapril",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Enalapril</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "44c94002",
      "audio": ""
    },
    {
      "text": "A 55-year-old man with a history of gastroesophageal reflux disease (GERD) consults his physician for treatment options. The physician recommends the use of rabeprazole, a proton pump inhibitor. Which of the following statements about proton pump inhibitors is incorrect?",
      "options": [
        {
          "label": "A",
          "text": "Proton pump inhibitors are available as enteric-coated tablets.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Proton pump inhibitors act from the luminal side of gastric parietal cells.",
          "correct": true
        },
        {
          "label": "C",
          "text": "Proton pump inhibitors are inactive at neutral pH.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Proton pump inhibitors should be taken half an hour before food",
          "correct": false
        }
      ],
      "correct_answer": "B. Proton pump inhibitors act from the luminal side of gastric parietal cells.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Proton pump inhibitors act from the luminal side of gastric parietal cells.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 A) Proton pump inhibitors are available as enteric-coated tablets: This statement is TRUE. The enteric coating allows the medication to pass through the stomach without being destroyed by the stomach acid, eventually dissolving in the intestine for absorption.</li><li>\u2022 B) Proton pump inhibitors act from the luminal side of gastric parietal cells: This statement is FALSE. Proton pump inhibitors, including rabeprazole, act from the acidic canaliculus inside the gastric parietal cell, not from the luminal side.</li><li>\u2022 C) Proton pump inhibitors are inactive at neutral pH: This statement is TRUE. Proton pump inhibitors are prodrugs that are activated in an acidic environment, which allows them to act specifically on the stomach's acid-secreting cells.</li><li>\u2022 D) Proton pump inhibitors should be taken half an hour before food: This statement is TRUE. Taking proton pump inhibitors around 30 minutes before eating ensures better activation of the drug, as the stomach starts producing acid in response to eating, thereby optimizing the drug's efficacy.</li><li>\u2022 Therefore, the statement that is INCORRECT regarding proton pump inhibitors is that they act from the luminal side of gastric parietal cells.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "774686b7",
      "audio": ""
    },
    {
      "text": "A 65-year-old male presents with symptoms of urinary urgency, frequency, and nocturia. He has been diagnosed with overactive bladder and his previous medication (oxybutynin) was not effective in managing his symptoms. Which of the following drugs is a beta-3 adrenergic receptor agonist that may be effective in treating this patient's symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Tolterodine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Memantine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Vibegron",
          "correct": true
        },
        {
          "label": "D",
          "text": "Levetiracetam",
          "correct": false
        }
      ],
      "correct_answer": "C. Vibegron",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Vibegron</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of all the options:</li><li>\u2022 A) Tolterodine: This drug is an antimuscarinic agent, not a beta-3 adrenergic receptor agonist. It is commonly used in the treatment of overactive bladder but works through a different mechanism of action than beta-3 adrenergic receptor agonists.</li><li>\u2022 B) Memantine: Memantine is an NMDA receptor antagonist used primarily in the treatment of moderate-to-severe Alzheimer's disease. It has no role in the treatment of overactive bladder.</li><li>\u2022 C) Vibegron: This is a beta-3 adrenergic receptor agonist (similar to mirabegron) that is used in the treatment of overactive bladder. By stimulating beta-3 adrenergic receptors in the detrusor muscle of the bladder, it relaxes the muscle and improves symptoms like urinary urgency and frequency.</li><li>\u2022 D) Levetiracetam: Levetiracetam is an antiepileptic drug that is used to treat various types of seizures. It has no role in the treatment of overactive bladder.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "227bc442",
      "audio": ""
    },
    {
      "text": "A patient is admitted to the emergency department for treatment of a drug overdose. The identity of the drug is unknown, but it is observed that when the urine pH is acidic, the renal clearance of the drug is less than GFR and that when the urine pH is alkaline, the clearance is greater than GFR. The drug probably is?",
      "options": [
        {
          "label": "A",
          "text": "Strong acid",
          "correct": false
        },
        {
          "label": "B",
          "text": "Weak acid",
          "correct": true
        },
        {
          "label": "C",
          "text": "Weak base",
          "correct": false
        },
        {
          "label": "D",
          "text": "Strong base",
          "correct": false
        }
      ],
      "correct_answer": "B. Weak acid",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Weak acid</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 When the urine pH is acidic, the renal clearance of a weak acid drug is less than the glomerular filtration rate (GFR). This is because in acidic urine, weak acid drugs remain predominantly in their non-ionized form, which hinders their excretion into the urine. As a result, their renal clearance is limited.</li><li>\u2022 On the other hand, when the urine pH is alkaline, the renal clearance of a weak acid drug is greater than the GFR. In alkaline urine, weak acid drugs become ionized, which promotes their excretion into the urine. This leads to a higher renal clearance compared to the GFR.</li><li>\u2022 Strong acids (Choice A) and strong bases (Choice D) are usually fully ionized and do not undergo significant changes in their excretion based on urine pH.</li><li>\u2022 Therefore, based on the observed changes in renal clearance in response to urine pH, the drug in question is most likely a weak acid (Choice B).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2683b6a9",
      "audio": ""
    },
    {
      "text": "A 43-year-old, insulin-dependent diabetic patient is diagnosed with hypertension and begins therapy with an antihypertensive agent. Three days later, he measures his blood glucose at home and finds that it is 53 mg/dL. He recalibrates his glucose testing apparatus and repeats the test, only to find that the first reading was accurate. He is concerned that his hypoglycemia did not produce the normal premonitory signs and symptoms. Which of the following medications was most likely prescribed to treat his hypertension?",
      "options": [
        {
          "label": "A",
          "text": "Captopril",
          "correct": false
        },
        {
          "label": "B",
          "text": "Diltiazem",
          "correct": false
        },
        {
          "label": "C",
          "text": "Methyldopa",
          "correct": false
        },
        {
          "label": "D",
          "text": "Propranolol",
          "correct": true
        }
      ],
      "correct_answer": "D. Propranolol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Propranolol</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8f463fa2",
      "audio": ""
    },
    {
      "text": "Which of the following statements is WRONG about amiodarone?",
      "options": [
        {
          "label": "A",
          "text": "It is the longest acting anti arrhythmic drug.",
          "correct": false
        },
        {
          "label": "B",
          "text": "It has positive ionotropic action.",
          "correct": true
        },
        {
          "label": "C",
          "text": "It contains iodine.",
          "correct": false
        },
        {
          "label": "D",
          "text": "It causes pulmonary fibrosis.",
          "correct": false
        }
      ],
      "correct_answer": "B. It has positive ionotropic action.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6db529a2",
      "audio": ""
    },
    {
      "text": "Metformin is least likely to reduce blood sugar in which of the following patients?",
      "options": [
        {
          "label": "A",
          "text": "Obese diabetics",
          "correct": false
        },
        {
          "label": "B",
          "text": "Non-diabetics",
          "correct": true
        },
        {
          "label": "C",
          "text": "Type 2 diabetics",
          "correct": false
        },
        {
          "label": "D",
          "text": "Diabetics not respond to sulfonylureas.",
          "correct": false
        }
      ],
      "correct_answer": "B. Non-diabetics",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Non-diabetics</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "24444d9b",
      "audio": ""
    },
    {
      "text": "A 48-year-old woman goes to her dermatologist to have a mole removed. The patient tells her physician that she had an allergic reaction to a local anesthetic the last time she had dental work performed. Examination of her dental records by her dentist reveals that the patient received chlorprocaine for a tooth extraction. Which of the following drugs would be appropriate for the present procedure?",
      "options": [
        {
          "label": "A",
          "text": "Benzocaine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Procaine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cocaine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lignocaine",
          "correct": true
        }
      ],
      "correct_answer": "D. Lignocaine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Lignocaine</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a5c842e5",
      "audio": ""
    },
    {
      "text": "Following the treatment of an oral abscess with clindamycin, a patient develops a greenish, foul-smelling watery diarrhea with left lower quadrant pain. Other signs and symptoms include fever, leukocytosis, and lethargy. If the toxin produced by Clostridium difficile is detected in the stool, the patient would most appropriately be treated with:",
      "options": [
        {
          "label": "A",
          "text": "Fidaxomicin",
          "correct": true
        },
        {
          "label": "B",
          "text": "Intravenous vancomycin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Loperamide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Metronidazole",
          "correct": false
        }
      ],
      "correct_answer": "A. Fidaxomicin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Fidaxomicin.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e0c175da",
      "audio": ""
    },
    {
      "text": "A 45-year-old female presents to the clinic with a palpable lump in her left breast that she noticed while showering. She reports no associated pain, discharge, or skin changes. Her past medical history is unremarkable, and she has no known family history of breast or ovarian cancer. Her last mammogram was two years ago and showed no abnormalities. After appropriate investigations including mammogram, ultrasound, and biopsy, she is diagnosed with stage II breast cancer. The biopsy reveals that the cancer is HER2-positive, but estrogen receptor (ER) and progesterone receptor (PR) negative. Which of the following drugs, a tyrosine kinase inhibitor, would be suitable for treating this patient's breast cancer?",
      "options": [
        {
          "label": "A",
          "text": "Sorafenib",
          "correct": false
        },
        {
          "label": "B",
          "text": "Imatinib",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pazopanib",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lapatinib",
          "correct": true
        }
      ],
      "correct_answer": "D. Lapatinib",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Lapatinib.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e0a57cea",
      "audio": ""
    },
    {
      "text": "A 52-year-old female patient is undergoing chemotherapy for breast cancer. The oncology team is concerned about the risk of febrile neutropenia due to the chemotherapeutic regimen. They are contemplating the use of a granulocyte colony-stimulating factor (G-CSF) and discuss the option of using pegylated-filgrastim. Which of the following is true about pegylated-filgrastim?",
      "options": [
        {
          "label": "A",
          "text": "Duration of action is longer than filgrastim",
          "correct": true
        },
        {
          "label": "B",
          "text": "Added advantage is that it can be taken orally",
          "correct": false
        },
        {
          "label": "C",
          "text": "It requires renal dose adjustment",
          "correct": false
        },
        {
          "label": "D",
          "text": "It is not effective in the treatment of severe neutropenia.",
          "correct": false
        }
      ],
      "correct_answer": "A. Duration of action is longer than filgrastim",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Duration of action is longer than filgrastim.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "37165975",
      "audio": ""
    },
    {
      "text": "A 62-year-old man is experiencing recurrent urinary tract infections. His healthcare team is considering various antibiotics, including fluoroquinolones, for his treatment. Which of the following fluoroquinolones is not typically effective for treating urinary tract infections?",
      "options": [
        {
          "label": "A",
          "text": "Ofloxacin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Levofloxacin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Moxifloxacin",
          "correct": true
        },
        {
          "label": "D",
          "text": "Lomefloxacin",
          "correct": false
        }
      ],
      "correct_answer": "C. Moxifloxacin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Moxifloxacin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of all the options:</li><li>\u2022 A) Ofloxacin: This fluoroquinolone is commonly used for treating urinary tract infections and is generally effective against a wide range of bacteria that can cause UTIs.</li><li>\u2022 B) Levofloxacin: This is another fluoroquinolone antibiotic frequently used in the treatment of UTIs and is generally effective for this purpose.</li><li>\u2022 C) Moxifloxacin: This is the correct answer. Moxifloxacin is generally not recommended for treating UTIs. It has reduced effectiveness against the typical bacteria that cause UTIs as compared to other fluoroquinolones.</li><li>\u2022 D) Lomefloxacin: Like ofloxacin and levofloxacin, lomefloxacin is generally effective for treating UTIs.</li><li>\u2022 Therefore, among the given options, Moxifloxacin is typically not effective for treating urinary tract infections.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2cf6af3c",
      "audio": ""
    },
    {
      "text": "Which of the following drugs act through intracellular receptors?",
      "options": [
        {
          "label": "A",
          "text": "Thyroxine",
          "correct": true
        },
        {
          "label": "B",
          "text": "Glucagon",
          "correct": false
        },
        {
          "label": "C",
          "text": "Epinephrine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Parathyroid hormone",
          "correct": false
        }
      ],
      "correct_answer": "A. Thyroxine",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/1.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Thyroxine</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7e41f215",
      "audio": ""
    },
    {
      "text": "A 35-year-old male patient with a history of chronic pain is being managed on an oral pain medication. The healthcare team is monitoring the patient's response to medication and decides to take periodic plasma concentration samples. The team wants to evaluate the rate at which the drug is absorbed into the patient's system. Which of the following parameters on a plasma concentration vs. time graph would be most indicative of the rate of drug absorption for this patient?",
      "options": [
        {
          "label": "A",
          "text": "AUC",
          "correct": false
        },
        {
          "label": "B",
          "text": "Half-life (T1/2)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cmax",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tmax",
          "correct": true
        }
      ],
      "correct_answer": "D. Tmax",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Tmax</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of Options:</li><li>\u2022 A) Area under the Curve (AUC): This parameter reflects the total drug exposure over time but does not give insights into the rate of drug absorption.</li><li>\u2022 B) Half-life (T1/2): This measures how long it takes for the drug concentration to decrease to half its initial value, more related to the elimination phase rather than the absorption rate.</li><li>\u2022 C) Maximum concentration (Cmax): This indicates the peak concentration of the drug in the bloodstream but doesn't specify how quickly this level is reached.</li><li>\u2022 D) Time to reach maximum concentration (Tmax): This is the time it takes for the drug to reach its peak concentration in the plasma. It gives an indication of how quickly the drug is absorbed into the system.</li><li>\u2022 Therefore, the time to reach maximum concentration (Tmax) is the best parameter to evaluate the rate of drug absorption.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "751ea758",
      "audio": ""
    },
    {
      "text": "Identify the type of inhibition given in the graph",
      "options": [
        {
          "label": "A",
          "text": "Competitive",
          "correct": false
        },
        {
          "label": "B",
          "text": "Un-competitive",
          "correct": false
        },
        {
          "label": "C",
          "text": "Non-competitive.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Allosteric",
          "correct": false
        }
      ],
      "correct_answer": "C. Non-competitive.",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/3.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/4.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Non-competitive.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f86a8701",
      "audio": ""
    },
    {
      "text": "A 55-year-old male patient with chronic gout is under consideration for a change in treatment plan due to poor response to conventional therapies like allopurinol and colchicine. The healthcare team is discussing the potential use of rasburicase. What is the mechanism of action of rasburicase?",
      "options": [
        {
          "label": "A",
          "text": "Inhibition of xanthine oxidase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Conversion of uric acid to allantoin",
          "correct": true
        },
        {
          "label": "C",
          "text": "Increase excretion of uric acid",
          "correct": false
        },
        {
          "label": "D",
          "text": "Inhibition of granulocyte migration",
          "correct": false
        }
      ],
      "correct_answer": "B. Conversion of uric acid to allantoin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Conversion of uric acid to allantoin.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5c6776a6",
      "audio": ""
    },
    {
      "text": "A 56-year-old woman has been diagnosed with stage IV melanoma and is scheduled to receive immune checkpoint inhibitor therapy. The physician explains the mechanism of action and potential side effects of immune checkpoint inhibitors to the patient and her family. Which of the following is true about immune checkpoint inhibitors?",
      "options": [
        {
          "label": "A",
          "text": "Nivolumab works by blocking the PD-1 receptor and is used to treat various types of cancer.",
          "correct": true
        },
        {
          "label": "B",
          "text": "Bevacizumab works by inhibiting angiogenesis and is used to treat solid tumors.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rituximab works by depleting B cells and is used to treat lymphoma and autoimmune disorders.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Trastuzumab works by targeting the HER2 receptor and is used to treat breast cancer.",
          "correct": false
        }
      ],
      "correct_answer": "A. Nivolumab works by blocking the PD-1 receptor and is used to treat various types of cancer.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Nivolumab works by blocking the PD-1 receptor and is used to treat various types of cancer.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Among the given options, only nivolumab is an immune check point inhibitor whereas other drugs mentioned in the options act by other mechanisms.</li><li>\u2022 Immune checkpoint inhibitors are a type of immunotherapy that work by releasing the brakes on the immune system, allowing it to attack cancer cells more effectively. Nivolumab is a monoclonal antibody that blocks the PD-1 receptor on T cells, which prevents the inhibition of T cell activation and enhances the immune system's ability to attack cancer cells. Nivolumab has been approved for the treatment of various types of cancer, including Hodgkin\u2019s lymphoma,  melanoma, non-small cell lung cancer, and kidney cancer. Bevacizumab is a monoclonal antibody against VEGF that inhibits angiogenesis, the formation of new blood vessels, and is used to treat solid tumors. Rituximab is a monoclonal antibody against CD20 that depletes B cells and is used to treat lymphoma and autoimmune disorders. Trastuzumab is a monoclonal antibody that targets the HER2 receptor and is used to treat breast cancer.</li><li>\u2022 Immune checkpoint inhibitors are a type of immunotherapy that work by releasing the brakes on the immune system, allowing it to attack cancer cells more effectively. Nivolumab is a monoclonal antibody that blocks the PD-1 receptor on T cells, which prevents the inhibition of T cell activation and enhances the immune system's ability to attack cancer cells. Nivolumab has been approved for the treatment of various types of cancer, including Hodgkin\u2019s lymphoma,  melanoma, non-small cell lung cancer, and kidney cancer.</li><li>\u2022 Bevacizumab is a monoclonal antibody against VEGF that inhibits angiogenesis, the formation of new blood vessels, and is used to treat solid tumors.</li><li>\u2022 Rituximab is a monoclonal antibody against CD20 that depletes B cells and is used to treat lymphoma and autoimmune disorders.</li><li>\u2022 Trastuzumab is a monoclonal antibody that targets the HER2 receptor and is used to treat breast cancer.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "da858743",
      "audio": ""
    },
    {
      "text": "Which of the following is not a correct match with respect to the mechanism of action and clinical use of the given drugs?",
      "options": [
        {
          "label": "A",
          "text": "Zavegepant - CGRP receptor antagonist used for the treatment of acute migraine attacks",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pembrolizumab \u2013 Immune check point inhibitor used for endometrial carcinoma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ertugliflozin \u2013 SGLT2 inhibitor for treatment of diabetes mellitus",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ivabradine \u2013 Funny current blocker for treatment of decreased visual acuity",
          "correct": true
        }
      ],
      "correct_answer": "D. Ivabradine \u2013 Funny current blocker for treatment of decreased visual acuity",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Ivabradine \u2013 Funny current blocker for treatment of decreased visual acuity.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of all the options:</li><li>\u2022 A) Zavegepant - CGRP receptor antagonist used for the treatment of acute migraine attacks: This is a correct match. Zavegepant is a calcitonin gene-related peptide (CGRP) receptor antagonist. It is used for the treatment of acute migraine attacks. CGRP is a neuropeptide that plays a role in the pathophysiology of migraines, and antagonists like Zavegepant block its activity, thereby alleviating symptoms.</li><li>\u2022 B) Pembrolizumab \u2013 Immune check point inhibitor used for endometrial carcinoma: This is also a correct match. Pembrolizumab is an immune checkpoint inhibitor that targets the PD-1 receptor. It is used for a variety of cancers, including endometrial carcinoma, especially in cases that are MSI-H or dMMR (microsatellite instability-high or mismatch repair deficient).</li><li>\u2022 C) Ertugliflozin \u2013 SGLT2 inhibitor for treatment of diabetes mellitus: This is another correct match. Ertugliflozin is a Sodium-Glucose Cotransporter-2 (SGLT2) inhibitor, which is used to manage blood sugar levels in type 2 diabetes mellitus. It works by inhibiting the reabsorption of glucose in the kidneys, thereby leading to the excretion of glucose in the urine.</li><li>\u2022 D) Ivabradine \u2013 Funny current blocker for treatment of decreased visual acuity: This is the incorrect match. Ivabradine is indeed a \"funny\" current (If) blocker, but it is used for the treatment of certain types of chronic heart failure and angina pectoris (chest pain), not for treating decreased visual acuity.</li><li>\u2022 Therefore, option D is not a correct match concerning the mechanism of action and clinical use of the given drug.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bc5def13",
      "audio": ""
    },
    {
      "text": "A 62-year-old male presents to the emergency department with chest pain and shortness of breath. The patient has a past medical history of hypertension and hyperlipidemia. An electrocardiogram (ECG) reveals ST-segment elevation. The patient is diagnosed with acute myocardial infarction (AMI) and undergoes percutaneous coronary intervention (PCI). The cardiologist orders the patient to take an antiplatelet drug after the procedure to prevent further clot formation. Which of the following best describes the mechanism of action of clopidogrel, a commonly used antiplatelet drug?",
      "options": [
        {
          "label": "A",
          "text": "Inhibits cyclooxygenase-1 (COX-1) and decreases production of thromboxane A2, thereby reducing platelet activation and aggregation.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Blocks the P2Y12 receptor on platelets, inhibiting the activation and aggregation of platelets.",
          "correct": true
        },
        {
          "label": "C",
          "text": "Inhibits the formation of fibrin by blocking the conversion of fibrinogen to fibrin.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Binds to glycoprotein IIb/IIIa receptors on the surface of activated platelets, preventing the aggregation of platelets.",
          "correct": false
        }
      ],
      "correct_answer": "B. Blocks the P2Y12 receptor on platelets, inhibiting the activation and aggregation of platelets.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Blocks the P2Y12 receptor on platelets, inhibiting the activation and aggregation of platelets.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B describes the mechanism of action of P2Y12 receptor inhibitors, such as clopidogrel, prasugrel, and ticagrelor. These drugs inhibit the activation and aggregation of platelets by blocking the P2Y12 receptor on the platelet surface. Option A: Aspirin irreversibly inhibits cyclooxygenase-1 (COX-1), which is responsible for the production of thromboxane A2, a potent platelet activator and aggregator. By decreasing the production of thromboxane A2, aspirin reduces the activation and aggregation of platelets, thereby preventing further clot formation. Aspirin is commonly used as an antiplatelet drug for the prevention of cardiovascular events, such as myocardial infarction and stroke. Option C describes the mechanism of action of anticoagulants, such as heparin and warfarin. These drugs inhibit the formation of fibrin by blocking the coagulation cascade and the conversion of fibrinogen to fibrin. Option D describes the mechanism of action of glycoprotein IIb/IIIa receptor inhibitors, such as abciximab, eptifibatide, and tirofiban. These drugs bind to glycoprotein IIb/IIIa receptors on the surface of activated platelets, preventing the aggregation of platelets.</li><li>\u2022 Option B describes the mechanism of action of P2Y12 receptor inhibitors, such as clopidogrel, prasugrel, and ticagrelor. These drugs inhibit the activation and aggregation of platelets by blocking the P2Y12 receptor on the platelet surface.</li><li>\u2022 Option A: Aspirin irreversibly inhibits cyclooxygenase-1 (COX-1), which is responsible for the production of thromboxane A2, a potent platelet activator and aggregator. By decreasing the production of thromboxane A2, aspirin reduces the activation and aggregation of platelets, thereby preventing further clot formation. Aspirin is commonly used as an antiplatelet drug for the prevention of cardiovascular events, such as myocardial infarction and stroke.</li><li>\u2022 Option C describes the mechanism of action of anticoagulants, such as heparin and warfarin. These drugs inhibit the formation of fibrin by blocking the coagulation cascade and the conversion of fibrinogen to fibrin.</li><li>\u2022 Option D describes the mechanism of action of glycoprotein IIb/IIIa receptor inhibitors, such as abciximab, eptifibatide, and tirofiban. These drugs bind to glycoprotein IIb/IIIa receptors on the surface of activated platelets, preventing the aggregation of platelets.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e3e27008",
      "audio": ""
    },
    {
      "text": "A 62-year-old female with a history of breast cancer presents to the clinic for a routine follow-up. She has recently completed a course of chemotherapy that included doxorubicin, cyclophosphamide, and paclitaxel. Shortly after her chemotherapy, she developed febrile neutropenia and was treated with filgrastim and cefepime. She also has a history of hypertension controlled with amlodipine. She now reports experiencing symptoms of shortness of breath, fatigue, and palpitations. An echocardiogram reveals her ejection fraction has decreased to 40%. What is the most likely drug-related cause of her reduced ejection fraction?",
      "options": [
        {
          "label": "A",
          "text": "Filgrastim",
          "correct": false
        },
        {
          "label": "B",
          "text": "Doxorubicin",
          "correct": true
        },
        {
          "label": "C",
          "text": "Cefepime",
          "correct": false
        },
        {
          "label": "D",
          "text": "Amlodipine",
          "correct": false
        }
      ],
      "correct_answer": "B. Doxorubicin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Doxorubicin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of all the options:</li><li>\u2022 A) Filgrastim: This drug is used to stimulate the production of neutrophils and is commonly used to treat febrile neutropenia. It is not generally associated with cardiomyopathy or a reduced ejection fraction.</li><li>\u2022 B) Doxorubicin: Doxorubicin is a chemotherapy agent known for its cardiotoxic effects, which can result in reduced ejection fraction and symptoms like shortness of breath, fatigue, and palpitations. Given the patient's recent chemotherapy regimen that included doxorubicin, this is the most likely cause of her decreased ejection fraction.</li><li>\u2022 C) Cefepime: This antibiotic is commonly used to treat bacterial infections, including those that may occur with febrile neutropenia. It is not typically associated with reduced ejection fraction or cardiomyopathy.</li><li>\u2022 D) Amlodipine: This drug is a calcium channel blocker used to treat hypertension. While it has cardiovascular effects, it is not generally associated with a reduced ejection fraction or cardiomyopathy.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "694cc7ec",
      "audio": ""
    },
    {
      "text": "Which of the following statements regarding varenicline is correct?",
      "options": [
        {
          "label": "A",
          "text": "Varenicline is a nicotine replacement therapy that delivers nicotine through a transdermal patch",
          "correct": false
        },
        {
          "label": "B",
          "text": "Varenicline is a selective serotonin reuptake inhibitor that is used to treat depression",
          "correct": false
        },
        {
          "label": "C",
          "text": "Varenicline is a partial agonist of the nicotinic acetylcholine receptor that is used to aid smoking cessation",
          "correct": true
        },
        {
          "label": "D",
          "text": "Varenicline is a long-acting beta2-agonist that is used to treat asthma",
          "correct": false
        }
      ],
      "correct_answer": "C. Varenicline is a partial agonist of the nicotinic acetylcholine receptor that is used to aid smoking cessation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Varenicline is a partial agonist of the nicotinic acetylcholine receptor that is used to aid smoking cessation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Varenicline is a medication that is used to aid smoking cessation. It is a partial agonist of the nicotinic acetylcholine receptor, which means that it binds to the receptor and activates it to a lesser extent than nicotine. This reduces the pleasurable effects of smoking and decreases nicotine cravings.</li><li>\u2022 Varenicline is a medication that is used to aid smoking cessation. It is a partial agonist of the nicotinic acetylcholine receptor, which means that it binds to the receptor and activates it to a lesser extent than nicotine. This reduces the pleasurable effects of smoking and decreases nicotine cravings.</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A. Varenicline is a nicotine replacement therapy that delivers nicotine through a transdermal patch: this is incorrect because varenicline is not a nicotine replacement therapy that delivers nicotine through a transdermal patch. Nicotine replacement therapies include nicotine gum, lozenges, patches, and inhalers.</li><li>\u2022 Option A.</li><li>\u2022 Varenicline is a nicotine replacement therapy that delivers nicotine through a transdermal patch:</li><li>\u2022 Option B. Varenicline is a selective serotonin reuptake inhibitor that is used to treat depression: this is incorrect because varenicline is not a selective serotonin reuptake inhibitor (SSRI). SSRIs are a class of medications that are primarily used to treat depression and anxiety disorders.</li><li>\u2022 Option B.</li><li>\u2022 Varenicline is a selective serotonin reuptake inhibitor that is used to treat depression:</li><li>\u2022 Option D. Varenicline is a long-acting beta2-agonist that is used to treat asthma: this is incorrect because varenicline is not a long-acting beta2-agonist (LABA). LABAs are a class of medications that are used to treat asthma and chronic obstructive pulmonary disease (COPD).</li><li>\u2022 Option D. Varenicline is a long-acting beta2-agonist that is used to treat asthma:</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1f571fa6",
      "audio": ""
    },
    {
      "text": "A 55-year-old man who received a kidney transplant three months ago is admitted to the hospital with high-grade fever, malaise, and abdominal discomfort. On examination, he exhibits right upper quadrant tenderness. Lab investigations reveal abnormal liver enzymes, and a blood culture returns positive for cytomegalovirus (CMV). His current immunosuppressive regimen includes tacrolimus. What is the primary pharmacological action of tacrolimus that might have predisposed this patient to develop a CMV infection?",
      "options": [
        {
          "label": "A",
          "text": "Inhibition of calcineurin",
          "correct": true
        },
        {
          "label": "B",
          "text": "Blockade of IL-2 receptor",
          "correct": false
        },
        {
          "label": "C",
          "text": "IMP dehydrogenase inhibition",
          "correct": false
        },
        {
          "label": "D",
          "text": "Dihydro-orotate dehydrogenase inhibition",
          "correct": false
        }
      ],
      "correct_answer": "A. Inhibition of calcineurin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Inhibition of calcineurin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of all the options:</li><li>\u2022 A) Inhibition of calcineurin: Tacrolimus acts by inhibiting calcineurin, which plays a pivotal role in T-cell activation. This immunosuppressive action can make the patient susceptible to infections such as CMV.</li><li>\u2022 B) Blockade of IL-2 receptor: This is a mechanism of other immunosuppressive drugs like basiliximab but not tacrolimus. Therefore, it is not relevant to the patient's current condition.</li><li>\u2022 C) IMP dehydrogenase inhibition: This is the mechanism of mycophenolate mofetil, another immunosuppressive drug. It is not applicable to tacrolimus.</li><li>\u2022 D) Dihydro-orotate dehydrogenase inhibition: This mechanism is associated with drugs like leflunomide but is not relevant to the action of tacrolimus.</li><li>\u2022 Thus, the primary pharmacological action of tacrolimus that might have predisposed this patient to develop a CMV infection is the inhibition of calcineurin.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d73d2f39",
      "audio": ""
    },
    {
      "text": "A 60-year-old female with a history of glaucoma presents to the ophthalmologist with complaints of blurred vision and eye irritation. The patient reports that she has been using an anti-glaucoma medication for the past six months, and her symptoms began to appear gradually over the past few weeks. Upon further evaluation, it is discovered that the patient has experienced darkening of the iris and eyelid skin as well as increased length, thickness, and pigmentation of the eyelashes. Which of the following anti-glaucoma drugs is likely to produce these adverse effects?",
      "options": [
        {
          "label": "A",
          "text": "Timolol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Latanoprost",
          "correct": true
        },
        {
          "label": "C",
          "text": "Brimonidine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Dorzolamide",
          "correct": false
        }
      ],
      "correct_answer": "B. Latanoprost",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Latanoprost.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "70c5085a",
      "audio": ""
    },
    {
      "text": "A 78-year-old woman is taken to a neurologist by her family members. After thorough evaluation, the neurologist suggests the possibility of starting Aducanumab therapy, and the patient's family starts researching the medication. Which of the following statements about Aducanumab is FALSE?",
      "options": [
        {
          "label": "A",
          "text": "Aducanumab is a monoclonal antibody.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Aducanumab works by inhibiting acetylcholinesterase to increase cholinergic transmission.",
          "correct": true
        },
        {
          "label": "C",
          "text": "Aducanumab has received FDA approval for the treatment of Alzheimer's disease.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Aducanumab targets amyloid-beta plaques in the brain.",
          "correct": false
        }
      ],
      "correct_answer": "B. Aducanumab works by inhibiting acetylcholinesterase to increase cholinergic transmission.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Aducanumab works by inhibiting acetylcholinesterase to increase cholinergic transmission.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of all the options:</li><li>\u2022 A) Aducanumab is a monoclonal antibody: This statement is TRUE. Aducanumab is a monoclonal antibody designed to treat Alzheimer's disease by targeting amyloid-beta plaques in the brain.</li><li>\u2022 B) Aducanumab works by inhibiting acetylcholinesterase to increase cholinergic transmission: This statement is FALSE. Aducanumab does not work by inhibiting acetylcholinesterase. Its primary mechanism is to target and remove amyloid-beta plaques.</li><li>\u2022 C) Aducanumab has received FDA approval for the treatment of Alzheimer's disease: This statement is TRUE. Although its approval has been met with some controversy and debate, Aducanumab has been conditionally approved by the FDA for the treatment of Alzheimer's disease.</li><li>\u2022 D) Aducanumab targets amyloid-beta plaques in the brain: This statement is TRUE. The drug is designed to bind to amyloid-beta plaques, thereby aiding in their removal and potentially slowing the progression of Alzheimer's disease, although definitive evidence for clinical benefit is still being evaluated.</li><li>\u2022 Thus, the statement that is FALSE about Aducanumab is that it works by inhibiting acetylcholinesterase to increase cholinergic transmission.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "49414e73",
      "audio": ""
    },
    {
      "text": "A 65-year-old male patient with a history of chronic obstructive pulmonary disease (COPD) is on theophylline therapy. He presents to the emergency department with symptoms of nausea, vomiting, and tremors. On examination, he has a heart rate of 110 beats per minute and a serum theophylline level of 30 mg/L (normal range 5-15 mg/L). Which of the following drugs is most likely responsible for the patient's symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Prednisone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Salbutamol",
          "correct": false
        },
        {
          "label": "C",
          "text": "Clarithromycin",
          "correct": true
        },
        {
          "label": "D",
          "text": "Montelukast",
          "correct": false
        }
      ],
      "correct_answer": "C. Clarithromycin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Clarithromycin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Clarithromycin can interact with theophylline by inhibiting its metabolism, leading to an increase in serum concentration and an increased risk of toxicity. Symptoms of theophylline toxicity include nausea, vomiting, tremors, seizures, and tachycardia. In severe cases, theophylline toxicity can lead to cardiac arrhythmias and seizures. Other drugs that can interact with theophylline include ciprofloxacin, erythromycin, and fluvoxamine.</li><li>\u2022 Clarithromycin can interact with theophylline by inhibiting its metabolism, leading to an increase in serum concentration and an increased risk of toxicity.</li><li>\u2022 Symptoms of theophylline toxicity include nausea, vomiting, tremors, seizures, and tachycardia. In severe cases, theophylline toxicity can lead to cardiac arrhythmias and seizures.</li><li>\u2022 Other drugs that can interact with theophylline include ciprofloxacin, erythromycin, and fluvoxamine.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "16a4b598",
      "audio": ""
    },
    {
      "text": "A 25-year-old patient with no significant medical history presents to the emergency department with a fever of 102\u00b0F and altered sensorium. Upon examination, you notice a petechial rash on the patient's arms and legs. You suspect meningococcal septicemia. Which of the following antibiotics is recommended as the first-line empiric therapy?",
      "options": [
        {
          "label": "A",
          "text": "Ceftriaxone",
          "correct": true
        },
        {
          "label": "B",
          "text": "Penicillin G",
          "correct": false
        },
        {
          "label": "C",
          "text": "Piperacillin-Tazobactam",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cotrimoxazole",
          "correct": false
        }
      ],
      "correct_answer": "A. Ceftriaxone",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/9.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Ceftriaxone</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Meningococcal septicemia is a medical emergency that requires prompt antibiotic therapy. Empiric therapy with intravenous ceftriaxone is recommended as the first-line treatment for suspected meningococcal septicemia. Penicillin G is an alternative option but is less commonly used due to increasing resistance. Piperacillin-tazobactam and cotrimoxazole are not recommended as first-line treatments for meningococcal septicemia. Definitive therapy should be based on culture and susceptibility results.</li><li>\u2022 Meningococcal septicemia is a medical emergency that requires prompt antibiotic therapy.</li><li>\u2022 Empiric therapy with intravenous ceftriaxone is recommended as the first-line treatment for suspected meningococcal septicemia.</li><li>\u2022 Penicillin G is an alternative option but is less commonly used due to increasing resistance.</li><li>\u2022 Piperacillin-tazobactam and cotrimoxazole are not recommended as first-line treatments for meningococcal septicemia.</li><li>\u2022 Definitive therapy should be based on culture and susceptibility results.</li><li>\u2022 DOC for empirical therapy of meningitis</li><li>\u2022 DOC for empirical therapy of meningitis</li><li>\u2022 Note:</li><li>\u2022 Note:</li><li>\u2022 Vancomycin is given to cover gram positive bacteria like Streptococcus pneumoniae and Staphylococcus (including MRSA) Ampicillin is given to cover Listeria Meropenem is given to cover gram negative bacteria Cefotaxime can be used in place of ceftriaxone Cefepime can be used in place of meropenem</li><li>\u2022 Vancomycin is given to cover gram positive bacteria like Streptococcus pneumoniae and Staphylococcus (including MRSA)</li><li>\u2022 Ampicillin is given to cover Listeria</li><li>\u2022 Meropenem is given to cover gram negative bacteria</li><li>\u2022 Cefotaxime can be used in place of ceftriaxone</li><li>\u2022 Cefepime can be used in place of meropenem</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "84184710",
      "audio": ""
    },
    {
      "text": "What does IP in the figure shown stands for:",
      "options": [
        {
          "label": "A",
          "text": "Drug is an instant release preparation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Meant for intra pulmonary use",
          "correct": false
        },
        {
          "label": "C",
          "text": "The standards according to Indian Pharmacopoeia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Drug tested preclinically via Intraperitoneal route",
          "correct": false
        }
      ],
      "correct_answer": "C. The standards according to Indian Pharmacopoeia",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/mcq-no-32-min.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. The standards according to Indian Pharmacopoeia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of all the options:</li><li>\u2022 a. Drug is an instant release preparation: The term \"IP\" on a drug strip doesn't typically signify that the drug is an instant release preparation. This would usually be denoted by terms like \"IR\" rather than \"IP.\"</li><li>\u2022 b. Meant for intra pulmonary use: The abbreviation \"IP\" is not commonly used to denote that a drug is meant for intrapulmonary use. Instead, you would likely see terms such as \"inhaler\" or \"nebulizer\" or specific abbreviations for pulmonary administration.</li><li>\u2022 c. The standards according to Indian Pharmacopoeia: This is the correct answer. The term \"IP\" is often used on pharmaceutical packaging in India to denote that the drug meets the standards laid out in the Indian Pharmacopoeia.</li><li>\u2022 d. Drug tested preclinically via IntraPeritoneal route: \"IP\" is commonly used as an abbreviation for intraperitoneal in scientific research, but it is unlikely to be used in this context on a drug strip meant for patient use.</li><li>\u2022 Therefore, the correct interpretation of \"IP\" on the drug strip of asthalin is that the drug complies with the standards of the Indian Pharmacopoeia.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b88e75e8",
      "audio": ""
    },
    {
      "text": "A new antiarrhythmic drug is found to be effective against both atrial and ventricular arrhythmias. Its effect on action potential is shown in the Figure. The effect of this new drug is most similar to?",
      "options": [
        {
          "label": "A",
          "text": "Lignocaine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Propanolol",
          "correct": false
        },
        {
          "label": "C",
          "text": "Encainide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Procainamide",
          "correct": true
        }
      ],
      "correct_answer": "D. Procainamide",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/11.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Procainamide</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b9312a6a",
      "audio": ""
    },
    {
      "text": "The following table gives the data of AUC of drug A alone and AUC of drug A when combined with drug B. p value is <0.01. Which of the following statement regarding these drugs is most correct?",
      "options": [
        {
          "label": "A",
          "text": "Drug B decreases the first pass metabolism of drug A",
          "correct": true
        },
        {
          "label": "B",
          "text": "Drug B increases the systemic metabolism of drug A",
          "correct": false
        },
        {
          "label": "C",
          "text": "Drug B decreases the intestinal absorption of drug A",
          "correct": false
        },
        {
          "label": "D",
          "text": "Drug B increases the renal clearance of drug A",
          "correct": false
        }
      ],
      "correct_answer": "A. Drug B decreases the first pass metabolism of drug A",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/12.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Drug B decreases the first pass metabolism of drug A</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d9d3c94e",
      "audio": ""
    },
    {
      "text": "A 15-year-old boy presents to the emergency room with agitation, mydriasis, and hot, dry skin. Physical examination reveals decreased bowel sounds and tachycardia. Assuming that he is suffering from a drug overdose, which class of drugs is most likely responsible for his symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Anticholinergic",
          "correct": true
        },
        {
          "label": "B",
          "text": "Cholinomimetic",
          "correct": false
        },
        {
          "label": "C",
          "text": "Opioid",
          "correct": false
        },
        {
          "label": "D",
          "text": "Salicylate",
          "correct": false
        }
      ],
      "correct_answer": "A. Anticholinergic",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "986c52f6",
      "audio": ""
    },
    {
      "text": "A drug effect that is produced by therapeutic doses of both timolol and amiodarone is blockade of:",
      "options": [
        {
          "label": "A",
          "text": "Cardiac Na channels",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cardiac K channels",
          "correct": false
        },
        {
          "label": "C",
          "text": "Beta-adrenoceptors",
          "correct": true
        },
        {
          "label": "D",
          "text": "Alpha-adrenoceptors",
          "correct": false
        }
      ],
      "correct_answer": "C. Beta-adrenoceptors",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Beta-adrenoceptors.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "661ae322",
      "audio": ""
    },
    {
      "text": "Mechanism of action of statins is:",
      "options": [
        {
          "label": "A",
          "text": "Inhibition of HMG - CoA synthase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Stimulation of HMG-CoA reductase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Indirect increase of LDL receptors synthesis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Inhibition of intestinal cholesterol absorption",
          "correct": false
        }
      ],
      "correct_answer": "C. Indirect increase of LDL receptors synthesis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Indirect increase of LDL receptor synthesis</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b3417b57",
      "audio": ""
    },
    {
      "text": "One of the health benefits of the use of combined oral contraceptives in pre-menopausal women is that these contraceptives reduce the risk of:",
      "options": [
        {
          "label": "A",
          "text": "Deep vein thrombosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Migraine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ischemic stroke",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ovarian cancer",
          "correct": true
        }
      ],
      "correct_answer": "D. Ovarian cancer",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Ovarian cancer</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2232c080",
      "audio": ""
    },
    {
      "text": "A 67-year-old postmenopausal woman with a history of osteoporosis is being evaluated for potential pharmacological treatments to strengthen her bones. She has tried lifestyle modifications, including weight-bearing exercises and calcium supplements, with limited improvement. Her physician is considering various pharmacological agents to inhibit osteoclastic activity and thereby prevent further bone loss. Which of the following medications does NOT primarily act by inhibiting osteoclasts?",
      "options": [
        {
          "label": "A",
          "text": "Denosumab",
          "correct": false
        },
        {
          "label": "B",
          "text": "Strontium ranelate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Teriparatide",
          "correct": true
        },
        {
          "label": "D",
          "text": "Raloxifene",
          "correct": false
        }
      ],
      "correct_answer": "C. Teriparatide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Teriparatide</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of Options:</li><li>\u2022 a) Denosumab: This is a monoclonal antibody that inhibits the RANKL (Receptor Activator for Nuclear Factor \u03ba B Ligand), which is essential for the formation and function of osteoclasts. Thus, it inhibits osteoclast activity.</li><li>\u2022 b) Strontium ranelate: This drug is used in the treatment of osteoporosis and works by both promoting bone formation and inhibiting bone resorption. It is thought to inhibit osteoclasts, although the exact mechanism is not well understood.</li><li>\u2022 c) Teriparatide: This is the correct answer. Teriparatide is a recombinant form of parathyroid hormone. It is actually an anabolic (bone-building) agent that stimulates osteoblast activity, rather than inhibiting osteoclasts.</li><li>\u2022 d) Raloxifene: This is a selective estrogen receptor modulator (SERM) that inhibits bone resorption by osteoclasts, thus serving to preserve bone mass in conditions like osteoporosis.</li><li>\u2022 Teriparatide does not inhibit osteoclasts but stimulates osteoblasts, making it the correct answer for the drug that does not act by inhibiting osteoclasts.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "91f36b20",
      "audio": ""
    },
    {
      "text": "A 45-year-old male with a history of bipolar disorder presents to the clinic with complaints of confusion, agitation, diarrhea, hand tremors, and excessive thirst. The patient reports taking lithium for the past year as part of his treatment plan. Recently, he also started taking hydrochlorothiazide for hypertension. On examination, the patient has a fine tremor in both hands and is noted to have a serum lithium level of 2.8 mEq/L. Which of the following is the most likely cause of the patient's elevated serum lithium level?",
      "options": [
        {
          "label": "A",
          "text": "Additive diuretic effect of hydrochlorothiazide and lithium.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Increased renal reabsorption of lithium due to hydrochlorothiazide.",
          "correct": true
        },
        {
          "label": "C",
          "text": "Decreased gastrointestinal absorption of lithium due to hydrochlorothiazide.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hydrochlorothiazide-induced enhancement of lithium metabolism.",
          "correct": false
        }
      ],
      "correct_answer": "B. Increased renal reabsorption of lithium due to hydrochlorothiazide.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Increased renal reabsorption of lithium due to hydrochlorothiazide.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of all the options:</li><li>\u2022 A) Additive diuretic effect of hydrochlorothiazide and lithium: While both hydrochlorothiazide and lithium can have diuretic effects, this option doesn't directly explain the elevated serum lithium level. The primary concern here is the elevated lithium level, not an additive diuretic effect.</li><li>\u2022 B) Increased renal reabsorption of lithium due to hydrochlorothiazide: Hydrochlorothiazide can increase the renal reabsorption of lithium, leading to elevated serum lithium levels and symptoms of toxicity. This is the most likely explanation for the patient's elevated lithium level.</li><li>\u2022 C) Decreased gastrointestinal absorption of lithium due to hydrochlorothiazide: This option is misleading because decreased gastrointestinal absorption of lithium would lead to lower serum lithium levels, not higher.</li><li>\u2022 D) Hydrochlorothiazide-induced enhancement of lithium metabolism: This is also a distractor. Enhancement of lithium metabolism would typically result in reduced serum lithium levels, not elevated levels.</li><li>\u2022 Therefore, the most likely cause for the elevated serum lithium level and symptoms in this patient is the increased renal reabsorption of lithium due to hydrochlorothiazide.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7b3c8401",
      "audio": ""
    },
    {
      "text": "A 45-year-old male with a history of epilepsy presents to the dentist with complaints of difficulty in eating and cleaning the teeth. On Examination, the findings were shown as seen in the diagram below. The patient reports that he has been taking an anti-epileptic drug for the past six months, and his symptoms began to appear gradually over the past few weeks. Which of the following anti-epileptic drugs is likely to produce these adverse effects?",
      "options": [
        {
          "label": "A",
          "text": "Carbamazepine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Gabapentin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Levetiracetam",
          "correct": false
        },
        {
          "label": "D",
          "text": "Phenytoin",
          "correct": true
        }
      ],
      "correct_answer": "D. Phenytoin",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/8.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Phenytoin.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5f1a55c3",
      "audio": ""
    },
    {
      "text": "A 70-year-old male patient with a history of heart failure and atrial fibrillation has been taking digoxin for several months. He recently started on a new medication for hypertension. He presents to the clinic with symptoms of nausea, vomiting, and visual disturbances. Which of the following drugs is most likely responsible for these symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Metformin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lisinopril",
          "correct": false
        },
        {
          "label": "C",
          "text": "Amlodipine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hydrochlorothiazide",
          "correct": true
        }
      ],
      "correct_answer": "D. Hydrochlorothiazide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Hydrochlorothiazide</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Symptoms of digoxin toxicity include nausea, vomiting, loss of appetite, and visual disturbances. Other symptoms can include dizziness, confusion, and changes in heart rate or rhythm. Hydrochlorothiazide can cause electrolyte abnormalities such as hypokalemia, which can increase the risk of digoxin toxicity. Metformin is an oral antidiabetic medication that does not interact with digoxin. Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor and amlodipine is a calcium channel blocker, both of which do not interact with digoxin.</li><li>\u2022 Symptoms of digoxin toxicity include nausea, vomiting, loss of appetite, and visual disturbances. Other symptoms can include dizziness, confusion, and changes in heart rate or rhythm. Hydrochlorothiazide can cause electrolyte abnormalities such as hypokalemia, which can increase the risk of digoxin toxicity.</li><li>\u2022 Metformin is an oral antidiabetic medication that does not interact with digoxin.</li><li>\u2022 Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor and amlodipine is a calcium channel blocker, both of which do not interact with digoxin.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "accf5941",
      "audio": ""
    },
    {
      "text": "Given image shows the Log DRC of a drug alone (A) and in the presence of antagonists (B and C). Identify the type of antagonism shown in curve B and curve C?",
      "options": [
        {
          "label": "A",
          "text": "B is competitive and C is non-competitive antagonist",
          "correct": true
        },
        {
          "label": "B",
          "text": "B is non-competitive an C is competitive antagonist",
          "correct": false
        },
        {
          "label": "C",
          "text": "Both are competitive antagonists",
          "correct": false
        },
        {
          "label": "D",
          "text": "Both are non-competitive antagonists",
          "correct": false
        }
      ],
      "correct_answer": "A. B is competitive and C is non-competitive antagonist",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/10.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. B is competitive and C is non-competitive antagonist</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 A. B is competitive and C is non-competitive antagonist: This is the correct answer. B shows a parallel shift to the right, which is characteristic of competitive antagonism. Increasing the concentration of the agonist can overcome the antagonist. C shows a reduction in the maximal response that the agonist can produce, characteristic of a non-competitive antagonist.</li><li>\u2022 B. B is non-competitive and C is competitive antagonist: This is incorrect. B shows a parallel shift to the right, which is indicative of competitive antagonism. C shows a reduction in the maximal response, which is indicative of non-competitive antagonism.</li><li>\u2022 C. Both are competitive antagonists: This is incorrect. Curve B shows characteristics of competitive antagonism, but curve C shows characteristics of non-competitive antagonism as it reduces the maximal response of the agonist.</li><li>\u2022 D. Both are non-competitive antagonists: This is incorrect. Curve B shows characteristics of competitive antagonism as it shifts parallel to the right, while curve C shows characteristics of non-competitive antagonism as it reduces the maximal response of the agonist.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6da57741",
      "audio": ""
    },
    {
      "text": "A young female presented with left sided severe throbbing headache associated with nausea, vomiting, photophobia and phonophobia. Which of the following is a new drug that can provide immediate relief to this patient?",
      "options": [
        {
          "label": "A",
          "text": "Propranolol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lasmiditan",
          "correct": true
        },
        {
          "label": "C",
          "text": "Topiramate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Erenumab",
          "correct": false
        }
      ],
      "correct_answer": "B. Lasmiditan",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Lasmiditan</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ec291cd4",
      "audio": ""
    },
    {
      "text": "Relative intensities of blocking effect (shown by symbol of +) of four drugs on different receptors is: Which drug is most likely to exacerbate the symptoms of Parkinsonism?",
      "options": [
        {
          "label": "A",
          "text": "Drug A",
          "correct": false
        },
        {
          "label": "B",
          "text": "Drug B",
          "correct": false
        },
        {
          "label": "C",
          "text": "Drug C",
          "correct": false
        },
        {
          "label": "D",
          "text": "Drug D",
          "correct": true
        }
      ],
      "correct_answer": "D. Drug D",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/13.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Drug D</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3c2892ab",
      "audio": ""
    },
    {
      "text": "Which of the following chelating agents can be used orally for the treatment of transfusion siderosis in thalassemia patients?",
      "options": [
        {
          "label": "A",
          "text": "Desferrioxamine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ferrioxamine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Deferipirone",
          "correct": true
        },
        {
          "label": "D",
          "text": "All of these",
          "correct": false
        }
      ],
      "correct_answer": "C. Deferipirone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Deferipirone.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "88065286",
      "audio": ""
    },
    {
      "text": "Which of the mechanism of antifungal drug is wrongly matched?",
      "options": [
        {
          "label": "A",
          "text": "Azoles- Inhibit ergosterol synthesis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Flucytosine- Inhibit microtubule",
          "correct": true
        },
        {
          "label": "C",
          "text": "Echinocandins- Inhibit glycan synthesis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Amphotericin B- Create artificial pores in the membrane",
          "correct": false
        }
      ],
      "correct_answer": "B. Flucytosine- Inhibit microtubule",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/14.jpg"
      ],
      "explanation": "<p><strong>Ans. B. Flucytosine: Inhibit microtubule</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4956732b",
      "audio": ""
    }
  ]
}